AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress
AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress
复制标题
AVE 0991 通过减少氧化应激减轻心脏肥大
DOI:
10.1016/j.bbrc.2015.09.050
复制
发表时间:
2016-06-10
影响因子:
3.1
通讯作者:
Chen, Yili
中科院分区:
文献类型:
--
作者:
Ma, Yuedong;Huang, Huiling;Chen, Yili
AVE 0991, the nonpeptide angiotensin-(1-7) (Ang-(1-7)) analog, is recognized as having beneficial cardiovascular effects. However, the mechanisms have not been fully elucidated. This study was designed to investigate the effects of AVE 0991 on cardiac hypertrophy and the mechanisms involved. Mice were underwent aortic banding to induce cardiac hypertrophy followed by the administration of AVE 0991 (20 mg kg-day (-1)) for 4 weeks. It was shown that AVE 0991 reduced left ventricular hypertrophy and improved heart function, characterized by decreases in left ventricular weight and left ventricular end diastolic diameter, and increases in ejection fraction. Moreover, AVE 0991 significantly down-regulated mean myocyte diameter and attenuate the gene expression of the hypertrophic markers. Furthermore, AVE 0991 inhibited the expression of NOX 2 and NOX 4, meaning that AVE 0991 reduced oxidative stress of cardiac hypertrophy mice. Our data showed that AVE 0991 treatment could attenuate cardiac hypertrophy and improve heart function, which may be due to reduce oxidative stress. (C) 2016 Published by Elsevier Inc.